Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Celestica, Inc (NYSE: CLS) was $279.86 for the day, up 3.67% from the previous closing price of $269.96. In other words, the price has increased by $3.67 from its previous closing price. On the day, 4.8 million shares were traded. CLS stock price reached its highest trading level at $296.8504 during the session, while it also had its lowest trading level at $276.3701.
Ratios:
Our analysis of CLS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 102.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 83.67. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 16, 2025, initiated with a Buy rating and assigned the stock a target price of $340.
On October 03, 2025, TD Securities Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $238.
On July 21, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $172.Citigroup initiated its Neutral rating on July 21, 2025, with a $172 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Wilson Michael Max sold 25,000 shares for $98.73 per share. The transaction valued at 2,468,250 led to the insider holds 1,784 shares of the business.
Agrawal Alok K. bought 3,672 shares of CLS for $438,694 on May 30 ’25. On Mar 31 ’25, another insider, Laurette Koellner, who serves as the Director of the company, bought 100,000 shares for $82.69 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 32222711808 and an Enterprise Value of 32892348416. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.79, and their Forward P/E ratio for the next fiscal year is 39.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.04 while its Price-to-Book (P/B) ratio in mrq is 18.31. Its current Enterprise Value per Revenue stands at 3.107 whereas that against EBITDA is 35.753.
Stock Price History:
The Beta on a monthly basis for CLS is 1.83, which has changed by 3.8401937 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $271.70, while it has fallen to a 52-week low of $55.30. The 50-Day Moving Average of the stock is 21.91%, while the 200-Day Moving Average is calculated to be 92.53%.
Shares Statistics:
CLS traded an average of 3.36M shares per day over the past three months and 3026580 shares per day over the past ten days. A total of 115.00M shares are outstanding, with a floating share count of 114.44M. Insiders hold about 0.52% of the company’s shares, while institutions hold 74.22% stake in the company. Shares short for CLS as of 1759190400 were 5343990 with a Short Ratio of 1.59, compared to 1756425600 on 5007172. Therefore, it implies a Short% of Shares Outstanding of 5343990 and a Short% of Float of 4.67.
Earnings Estimates
Celestica, Inc (CLS) is presently subject to a detailed evaluation by 15.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $1.52, with high estimates of $1.81 and low estimates of $1.38.
Analysts are recommending an EPS of between $5.98 and $5.45 for the fiscal current year, implying an average EPS of $5.6. EPS for the following year is $7.12, with 17.0 analysts recommending between $9.6 and $6.35.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 14 analysts. It ranges from a high estimate of $3.16B to a low estimate of $2.99B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.5BFor the next quarter, 14 analysts are estimating revenue of $3.09B. There is a high estimate of $3.5B for the next quarter, whereas the lowest estimate is $2.82B.
A total of 16 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.2B, while the lowest revenue estimate was $11.38B, resulting in an average revenue estimate of $11.7B. In the same quarter a year ago, actual revenue was $9.65BBased on 15 analysts’ estimates, the company’s revenue will be $14.01B in the next fiscal year. The high estimate is $16.86B and the low estimate is $13.3B.
